Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1989 Jul;63(7):2941–2950. doi: 10.1128/jvi.63.7.2941-2950.1989

Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function.

J A Beeler 1, K van Wyke Coelingh 1
PMCID: PMC250848  PMID: 2470922

Abstract

Eighteen neutralizing monoclonal antibodies (MAbs) specific for the fusion glycoprotein of the A2 strain of respiratory syncytial virus (RSV) were used to construct a detailed topological and operational map of epitopes involved in neutralization and fusion. Competitive binding assays identified three nonoverlapping antigenic sites (A, B, and C) and one bridge site (AB). Thirteen MAb-resistant mutants (MARMs) were selected, and the neutralization patterns of the MAbs with either MARMs or RSV clinical strains identified a minimum of 16 epitopes. MARMs selected with antibodies to six of the site A and AB epitopes displayed a small-plaque phenotype, which is consistent with an alteration in a biologically active region of the F molecule. Analysis of MARMs also indicated that these neutralization epitopes occupy topographically distinct but conformationally interdependent regions with unique biological and immunological properties. Antigenic variation in F epitopes was examined by using 23 clinical isolates (18 subgroup A and 5 subgroup B) in cross-neutralization assays with the 18 anti-F MAbs. This analysis identified constant, variable, and hypervariable regions on the molecule and indicated that antigenic variation in the neutralization epitopes of the RSV F glycoprotein is the result of a noncumulative genetic heterogeneity. Of the 16 eptiopes, 8 were conserved on all or all but 1 of 23 subgroup A or subgroup B clinical isolates.

Full text

PDF
2941

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abenes G., Kida H., Yanagawa R. Antigenic mapping and functional analysis of the F protein of Newcastle disease virus using monoclonal antibodies. Arch Virol. 1986;90(1-2):97–110. doi: 10.1007/BF01314148. [DOI] [PubMed] [Google Scholar]
  2. Akerlind B., Norrby E. Occurrence of respiratory syncytial virus subtypes A and B strains in Sweden. J Med Virol. 1986 Jul;19(3):241–247. doi: 10.1002/jmv.1890190306. [DOI] [PubMed] [Google Scholar]
  3. Anderson L. J., Coombs R. A., Tsou C., Hierholzer J. C. Use of the biotin-avidin system to study the specificity of antibodies against respiratory syncytial virus. J Clin Microbiol. 1984 Jun;19(6):934–936. doi: 10.1128/jcm.19.6.934-936.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anderson L. J., Hierholzer J. C., Tsou C., Hendry R. M., Fernie B. F., Stone Y., McIntosh K. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis. 1985 Apr;151(4):626–633. doi: 10.1093/infdis/151.4.626. [DOI] [PubMed] [Google Scholar]
  5. Baybutt H. N., Pringle C. R. Molecular cloning and sequencing of the F and 22K membrane protein genes of the RSS-2 strain of respiratory syncytial virus. J Gen Virol. 1987 Nov;68(Pt 11):2789–2796. doi: 10.1099/0022-1317-68-11-2789. [DOI] [PubMed] [Google Scholar]
  6. Buckley A., Gould E. A. Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies. J Gen Virol. 1985 Dec;66(Pt 12):2523–2531. doi: 10.1099/0022-1317-66-12-2523. [DOI] [PubMed] [Google Scholar]
  7. COATES H. V., KENDRICK L., CHANOCK R. M. Antigenic differences between two strains of respiratory syncytial virus. Proc Soc Exp Biol Med. 1963 Apr;112:958–964. doi: 10.3181/00379727-112-28221. [DOI] [PubMed] [Google Scholar]
  8. Carrigan D. R. Round cell variant of measles virus: spontaneous conversion from productive to cell-associated state of infection. Virology. 1985 Jul 30;144(2):337–350. doi: 10.1016/0042-6822(85)90276-4. [DOI] [PubMed] [Google Scholar]
  9. Coates H. V., Alling D. W., Chanock R. M. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. Am J Epidemiol. 1966 Mar;83(2):299–313. doi: 10.1093/oxfordjournals.aje.a120586. [DOI] [PubMed] [Google Scholar]
  10. Collins P. L., Huang Y. T., Wertz G. W. Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7683–7687. doi: 10.1073/pnas.81.24.7683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fenner M., Binz H. Monoclonal antibodies specific for Sendai virus. I. Production and characterization of monoclonal antibodies. Scand J Immunol. 1986 Sep;24(3):335–340. doi: 10.1111/j.1365-3083.1986.tb02102.x. [DOI] [PubMed] [Google Scholar]
  12. Fernie B. F., Cote P. J., Jr, Gerin J. L. Classification of hybridomas to respiratory syncytial virus glycoproteins. Proc Soc Exp Biol Med. 1982 Dec;171(3):266–271. doi: 10.3181/00379727-171-41509. [DOI] [PubMed] [Google Scholar]
  13. Fernie B. F., Gerin J. L. The stabilization and purification of respiratory syncytial virus using MgSO4. Virology. 1980 Oct 15;106(1):141–144. doi: 10.1016/0042-6822(80)90229-9. [DOI] [PubMed] [Google Scholar]
  14. Flamand A., Wiktor T. J., Koprowski H. Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein. J Gen Virol. 1980 May;48(1):105–109. doi: 10.1099/0022-1317-48-1-105. [DOI] [PubMed] [Google Scholar]
  15. Gerhard W., Webster R. G. Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies. J Exp Med. 1978 Aug 1;148(2):383–392. doi: 10.1084/jem.148.2.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gimenez H. B., Cash P., Melvin W. T. Monoclonal antibodies to human respiratory syncytial virus and their use in comparison of different virus isolates. J Gen Virol. 1984 May;65(Pt 5):963–971. doi: 10.1099/0022-1317-65-5-963. [DOI] [PubMed] [Google Scholar]
  17. Gimenez H. B., Hardman N., Keir H. M., Cash P. Antigenic variation between human respiratory syncytial virus isolates. J Gen Virol. 1986 May;67(Pt 5):863–870. doi: 10.1099/0022-1317-67-5-863. [DOI] [PubMed] [Google Scholar]
  18. Hendry R. M., Talis A. L., Godfrey E., Anderson L. J., Fernie B. F., McIntosh K. Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks. J Infect Dis. 1986 Feb;153(2):291–297. doi: 10.1093/infdis/153.2.291. [DOI] [PubMed] [Google Scholar]
  19. Hsu M. C., Scheid A., Choppin P. W. Protease activation mutants of Sendai virus: sequence analysis of the mRNA of the fusion protein (F) gene and direct identification of the cleavage-activation site. Virology. 1987 Jan;156(1):84–90. doi: 10.1016/0042-6822(87)90438-7. [DOI] [PubMed] [Google Scholar]
  20. Iorio R. M., Bratt M. A. Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sites. J Immunol. 1984 Oct;133(4):2215–2219. [PubMed] [Google Scholar]
  21. Itoh M., Shibuta H., Homma M. Single amino acid substitution of Sendai virus at the cleavage site of the fusion protein confers trypsin resistance. J Gen Virol. 1987 Nov;68(Pt 11):2939–2944. doi: 10.1099/0022-1317-68-11-2939. [DOI] [PubMed] [Google Scholar]
  22. Johnson P. R., Collins P. L. The fusion glycoproteins of human respiratory syncytial virus of subgroups A and B: sequence conservation provides a structural basis for antigenic relatedness. J Gen Virol. 1988 Oct;69(Pt 10):2623–2628. doi: 10.1099/0022-1317-69-10-2623. [DOI] [PubMed] [Google Scholar]
  23. Johnson P. R., Jr, Olmsted R. A., Prince G. A., Murphy B. R., Alling D. W., Walsh E. E., Collins P. L. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol. 1987 Oct;61(10):3163–3166. doi: 10.1128/jvi.61.10.3163-3166.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Johnson P. R., Spriggs M. K., Olmsted R. A., Collins P. L. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5625–5629. doi: 10.1073/pnas.84.16.5625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Köhler G., Milstein C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol. 1976 Jul;6(7):511–519. doi: 10.1002/eji.1830060713. [DOI] [PubMed] [Google Scholar]
  26. Merz D. C., Scheid A., Choppin P. W. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med. 1980 Feb 1;151(2):275–288. doi: 10.1084/jem.151.2.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Merz D. C., Wolinsky J. S. Conversion of nonfusing mumps virus infections to fusing infections by selective proteolysis of the HN glycoprotein. Virology. 1983 Dec;131(2):328–340. doi: 10.1016/0042-6822(83)90501-9. [DOI] [PubMed] [Google Scholar]
  28. Morgan L. A., Routledge E. G., Willcocks M. M., Samson A. C., Scott R., Toms G. L. Strain variation of respiratory syncytial virus. J Gen Virol. 1987 Nov;68(Pt 11):2781–2788. doi: 10.1099/0022-1317-68-11-2781. [DOI] [PubMed] [Google Scholar]
  29. Mufson M. A., Belshe R. B., Orvell C., Norrby E. Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections. J Clin Microbiol. 1987 Aug;25(8):1535–1539. doi: 10.1128/jcm.25.8.1535-1539.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mufson M. A., Orvell C., Rafnar B., Norrby E. Two distinct subtypes of human respiratory syncytial virus. J Gen Virol. 1985 Oct;66(Pt 10):2111–2124. doi: 10.1099/0022-1317-66-10-2111. [DOI] [PubMed] [Google Scholar]
  31. Murphy B. R., Walsh E. E. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity. J Clin Microbiol. 1988 Aug;26(8):1595–1597. doi: 10.1128/jcm.26.8.1595-1597.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Norrby E., Gollmar Y. Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect Immun. 1975 Feb;11(2):231–239. doi: 10.1128/iai.11.2.231-239.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Olmsted R. A., Elango N., Prince G. A., Murphy B. R., Johnson P. R., Moss B., Chanock R. M., Collins P. L. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7462–7466. doi: 10.1073/pnas.83.19.7462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Orvell C., Norrby E., Mufson M. A. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B. J Gen Virol. 1987 Dec;68(Pt 12):3125–3135. doi: 10.1099/0022-1317-68-12-3125. [DOI] [PubMed] [Google Scholar]
  35. Portner A., Scroggs R. A., Metzger D. W. Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus. Virology. 1987 May;158(1):61–68. doi: 10.1016/0042-6822(87)90238-8. [DOI] [PubMed] [Google Scholar]
  36. Portner A., Scroggs R. A., Naeve C. W. The fusion glycoprotein of Sendai virus: sequence analysis of an epitope involved in fusion and virus neutralization. Virology. 1987 Apr;157(2):556–559. doi: 10.1016/0042-6822(87)90301-1. [DOI] [PubMed] [Google Scholar]
  37. Pothier P., Ghim S., Bour T. B., Gouyon J. B., Dauvergne M. Antigenic variations of respiratory syncytial virus in recurrent infections. Eur J Clin Microbiol. 1987 Apr;6(2):212–212. doi: 10.1007/BF02018219. [DOI] [PubMed] [Google Scholar]
  38. Prince G. A., Horswood R. L., Koenig D. W., Chanock R. M. Antigenic analysis of a putative new strain of respiratory syncytial virus. J Infect Dis. 1985 Apr;151(4):634–637. doi: 10.1093/infdis/151.4.634. [DOI] [PubMed] [Google Scholar]
  39. Routledge E. G., Willcocks M. M., Morgan L., Samson A. C., Scott R., Toms G. L. Heterogeneity of the respiratory syncytial virus 22K protein revealed by Western blotting with monoclonal antibodies. J Gen Virol. 1987 Apr;68(Pt 4):1209–1215. doi: 10.1099/0022-1317-68-4-1209. [DOI] [PubMed] [Google Scholar]
  40. Sato T. A., Fukuda A., Sugiura A. Characterization of major structural proteins of measles virus with monoclonal antibodies. J Gen Virol. 1985 Jul;66(Pt 7):1397–1409. doi: 10.1099/0022-1317-66-7-1397. [DOI] [PubMed] [Google Scholar]
  41. Shioda T., Wakao S., Suzu S., Shibuta H. Differences in bovine parainfluenza 3 virus variants studied by sequencing of the genes of viral envelope proteins. Virology. 1988 Feb;162(2):388–396. doi: 10.1016/0042-6822(88)90479-5. [DOI] [PubMed] [Google Scholar]
  42. Smith D. B., Inglis S. C. The mutation rate and variability of eukaryotic viruses: an analytical review. J Gen Virol. 1987 Nov;68(Pt 11):2729–2740. doi: 10.1099/0022-1317-68-11-2729. [DOI] [PubMed] [Google Scholar]
  43. Stanley J., Cooper S. J., Griffin D. E. Alphavirus neurovirulence: monoclonal antibodies discriminating wild-type from neuroadapted Sindbis virus. J Virol. 1985 Oct;56(1):110–119. doi: 10.1128/jvi.56.1.110-119.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Storch G. A., Park C. S. Monoclonal antibodies demonstrate heterogeneity in the G glycoprotein of prototype strains and clinical isolates of respiratory syncytial virus. J Med Virol. 1987 Aug;22(4):345–356. doi: 10.1002/jmv.1890220407. [DOI] [PubMed] [Google Scholar]
  45. Tikasingh E. S., Spence L., Downs W. G. The use of adjuvant and sarcoma 180 cells in the production of mouse hyperimmune ascitic fluids to arboviruses. Am J Trop Med Hyg. 1966 Mar;15(2):219–226. doi: 10.4269/ajtmh.1966.15.219. [DOI] [PubMed] [Google Scholar]
  46. Trudel M., Nadon F., Seguin C., Dionne G., Lacroix M. Identification of a synthetic peptide as part of a major neutralization epitope of respiratory syncytial virus. J Gen Virol. 1987 Sep;68(Pt 9):2273–2280. doi: 10.1099/0022-1317-68-9-2273. [DOI] [PubMed] [Google Scholar]
  47. WULFF H., KIDD P., WENNER H. A. RESPIRATORY SYNCYTIAL VIRUS: OBSERVATIONS ON ANTIGENIC HETEROGENEITY. Proc Soc Exp Biol Med. 1964 Jan;115:240–243. doi: 10.3181/00379727-115-28880. [DOI] [PubMed] [Google Scholar]
  48. Walsh E. E., Brandriss M. W., Schlesinger J. J. Immunological differences between the envelope glycoproteins of two strains of human respiratory syncytial virus. J Gen Virol. 1987 Aug;68(Pt 8):2169–2176. doi: 10.1099/0022-1317-68-8-2169. [DOI] [PubMed] [Google Scholar]
  49. Walsh E. E., Cote P. J., Fernie B. F., Schlesinger J. J., Brandriss M. W. Analysis of the respiratory syncytial virus fusion protein using monoclonal and polyclonal antibodies. J Gen Virol. 1986 Mar;67(Pt 3):505–513. doi: 10.1099/0022-1317-67-3-505. [DOI] [PubMed] [Google Scholar]
  50. Wang M. L., Skehel J. J., Wiley D. C. Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera. J Virol. 1986 Jan;57(1):124–128. doi: 10.1128/jvi.57.1.124-128.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Ward K. A., Everson J. S., Lambden P. R., Watt P. J. Antigenic and structural variation in the major nucleocapsid protein of respiratory syncytial virus. J Gen Virol. 1984 Oct;65(Pt 10):1749–1757. doi: 10.1099/0022-1317-65-10-1749. [DOI] [PubMed] [Google Scholar]
  52. Webster R. G., Laver W. G., Air G. M., Ward C., Gerhard W., van Wyke K. L. The mechanism of antigenic drift in influenza viruses: analysis of Hong Kong (H3N2) variants with monoclonal antibodies to the hemagglutinin molecule. Ann N Y Acad Sci. 1980;354:142–161. doi: 10.1111/j.1749-6632.1980.tb27964.x. [DOI] [PubMed] [Google Scholar]
  53. van Wyke Coelingh K. L., Winter C. C., Jorgensen E. D., Murphy B. R. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities. J Virol. 1987 May;61(5):1473–1477. doi: 10.1128/jvi.61.5.1473-1477.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. van Wyke Coelingh K. L., Winter C., Murphy B. R. Antigenic variation in the hemagglutinin-neuraminidase protein of human parainfluenza type 3 virus. Virology. 1985 Jun;143(2):569–582. doi: 10.1016/0042-6822(85)90395-2. [DOI] [PubMed] [Google Scholar]
  55. van Wyke Coelingh K., Tierney E. L. Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein. J Virol. 1989 Jan;63(1):375–382. doi: 10.1128/jvi.63.1.375-382.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES